3 results
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
Durvalumab after ... the Intention-to-Treat ... #EBM #Honc #PACIFIC ... #Durvalumab #NSCLC ... #NEJM
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma - Recurrence-free Survival in the
Stage III or IV Melanoma ... the Intention-to-Treat ... Population #EBM ... #Honc #Nivolumab ... #NEJM
Melanoma of the Foot - The physical examination revealed a well-defined, fleshy, reddish plaque measuring 2
Melanoma of the ... surface and black areas ... #Clinical #Derm ... #Podiatry #Honc ... #Foot #NEJM